These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38737664)

  • 21. Guillain-Barré syndrome as the first manifestation of SARS-CoV-2 infection.
    Barrachina-Esteve O; Palau Domínguez A; Hidalgo-Torrico I; Viguera Martínez ML
    Neurologia (Engl Ed); 2020; 35(9):710-712. PubMed ID: 32891435
    [No Abstract]   [Full Text] [Related]  

  • 22. [SARS-CoV-2, a new causal agent of Guillain-Barre syndrome].
    Redondo-Urda MJ; Rodríguez-Peguero FJ; Pérez-Gil O; Del Valle-Sánchez M; Carrera-Izquierdo M
    Rev Neurol; 2020 Oct; 71(7):275-276. PubMed ID: 32959360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review.
    Agosti E; Giorgianni A; D'Amore F; Vinacci G; Balbi S; Locatelli D
    Neurol Sci; 2021 Feb; 42(2):607-612. PubMed ID: 32643136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critically Severe COVID-19 in a Child with Residual Motor Deficit Due to Guillain-Barré Syndrome.
    Prijic A; Gazibara T; Nikolić D; Ostojić O; Maksimovic N
    Klin Padiatr; 2022 Mar; 234(2):123-126. PubMed ID: 34530473
    [No Abstract]   [Full Text] [Related]  

  • 25. SARS-CoV-2-Associated Guillain-Barre Syndrome With Good Response to Plasmapheresis.
    Granger A; Omari M; Jakubowska-Sadowska K; Boffa M; Zakin E
    J Clin Neuromuscul Dis; 2020 Sep; 22(1):58-59. PubMed ID: 32833726
    [No Abstract]   [Full Text] [Related]  

  • 26. A case report of Guillain-Barré syndrome in a pregnant woman infected by COVID-19.
    Mehrpour M; Arab M; Hadavand F; Khalafi M; Khalafi M
    Acta Neurol Belg; 2021 Aug; 121(4):1079-1080. PubMed ID: 34080170
    [No Abstract]   [Full Text] [Related]  

  • 27. A unique case of Miller Fisher-Guillain-Barré overlap syndrome in a liver transplant recipient.
    Ramirez-Sanchez C; Syed R; Meier A; LaBuzetta JN; Hylton DJ; Taremi M
    J Neurovirol; 2021 Oct; 27(5):797-801. PubMed ID: 34550544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection.
    Das KY; Midhun Raj KT; Samprathi M; Sridhar M; Adiga R; Vemgal P
    Indian J Pediatr; 2021 May; 88(5):479. PubMed ID: 33558992
    [No Abstract]   [Full Text] [Related]  

  • 29. The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation.
    Biassoni E; Assini A; Gandoglia I; Benedetti L; Boni S; Pontali E; Feasi M; Gandolfo F; Del Sette M
    J Neurovirol; 2021 Aug; 27(4):662-665. PubMed ID: 34341959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2, a new causative agent of Guillain-Barré syndrome?
    Esteban Molina A; Mata Martínez M; Sánchez Chueca P; Carrillo López A
    Med Intensiva (Engl Ed); 2022 Feb; 46(2):110-111. PubMed ID: 34887232
    [No Abstract]   [Full Text] [Related]  

  • 31. First Report of SARS-CoV-2 Detection in Cerebrospinal Fluid in a Child With Guillain-Barré Syndrome.
    Araújo NM; Ferreira LC; Dantas DP; Silva DS; Dos Santos CA; Cipolotti R; Martins-Filho PR
    Pediatr Infect Dis J; 2021 Jul; 40(7):e274-e276. PubMed ID: 33990525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 associated Guillain-Barré syndrome.
    Pelea T; Reuter U; Schmidt C; Laubinger R; Siegmund R; Walther BW
    J Neurol; 2021 Apr; 268(4):1191-1194. PubMed ID: 32770414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 associated Guillain-Barre syndrome after awaking on the ICU: consider differentials.
    Finsterer J
    Tuberk Toraks; 2021 Sep; 69(3):429-430. PubMed ID: 34581168
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 provoking Guillain-Barré syndrome: The Bergamo case series.
    Foresti C; Servalli MC; Frigeni B; Rifino N; Storti B; Gritti P; Fabretti F; Grazioli L; Sessa M
    Eur J Neurol; 2021 Oct; 28(10):e84-e85. PubMed ID: 32961593
    [No Abstract]   [Full Text] [Related]  

  • 35. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
    Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
    J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit.
    Diaz P; Leveque M; Hautecloque G; Sellal F; Augereau O; Lita L; Biegle E; Belilita L; Bouterra C; Rerat P; Alvarez-Gonzalez A; Martinot M; Gerber V
    J Neuroimmunol; 2022 May; 366():577842. PubMed ID: 35339941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia.
    Su XW; Palka SV; Rao RR; Chen FS; Brackney CR; Cambi F
    Muscle Nerve; 2020 Aug; 62(2):E48-E49. PubMed ID: 32445201
    [No Abstract]   [Full Text] [Related]  

  • 38. Guillain-Barré syndrome associated with COVID-19: a case report study.
    Nejad JH; Heiat M; Hosseini MJ; Allahyari F; Lashkari A; Torabi R; Ranjbar R
    J Neurovirol; 2021 Oct; 27(5):802-805. PubMed ID: 34046865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
    Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
    Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post SARS-CoV-2 Guillain-Barré syndrome.
    Arnaud S; Budowski C; Ng Wing Tin S; Degos B
    Clin Neurophysiol; 2020 Jul; 131(7):1652-1654. PubMed ID: 32422529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.